In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation

Jung Sik Kim, Jong Hyung Lim, Hye Young Nam, Hyun Ju Lim, Jun Seop Shin, Jin Young Shin, Ju Hee Ryu, Kwang Meyung Kim, Ick Chan Kwon, Sang Man Jin, Hang Rae Kim, Sang Joon Kim, Chung Gyu Park

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Maximum engraftment of transplanted islets is essential for the clinical application of a subcutaneous site. Significant barriers to the current approaches are associated with their low effectiveness, complexity and unproven biosafety. Here, we evaluated and optimized a fibrin-islet composite for effective glycemic control in a subcutaneous site whose environment is highly hypoxic due to low vascularization potential. In the setting of xenogeneic porcine islet transplantation into the subcutaneous space of a diabetic mouse, the in vivo islet functions were greatly affected by the concentrations of fibrinogen and thrombin. The optimized hydrogel-type fibrin remarkably reduced the marginal islet mass to approximately one tenth that of islets without fibrin. This marginal islet mass was comparable to that in the setting of the subcapsular space of the kidney, which is a highly vascularized organ. Highly vascularized structures were generated inside and on the outer surface of the grafts. A hydrogel-type fibrin-islet composite established early diabetic control within an average of 3.4 days after the transplantation. In the mechanistic studies, fibrin promoted local angiogenesis, enhanced islet viability and prevented fragmentation of islets into single cells. In conclusion, in situ application of hydrogel-type fibrin-islet composite may be a promising modality in the clinical success of subcutaneous islet transplantation.

Original languageEnglish
Pages (from-to)382-390
Number of pages9
JournalJournal of Controlled Release
Volume162
Issue number2
DOIs
Publication statusPublished - 2012 Sep 10
Externally publishedYes

Fingerprint

Islets of Langerhans Transplantation
Hydrogel
Fibrin
Swine
Thrombin
Fibrinogen
Transplantation
Transplants
Kidney

Keywords

  • Fibrin
  • Porcine islet
  • Subcutaneous islet transplantation
  • Xenotransplantation

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. / Kim, Jung Sik; Lim, Jong Hyung; Nam, Hye Young; Lim, Hyun Ju; Shin, Jun Seop; Shin, Jin Young; Ryu, Ju Hee; Kim, Kwang Meyung; Kwon, Ick Chan; Jin, Sang Man; Kim, Hang Rae; Kim, Sang Joon; Park, Chung Gyu.

In: Journal of Controlled Release, Vol. 162, No. 2, 10.09.2012, p. 382-390.

Research output: Contribution to journalArticle

Kim, Jung Sik ; Lim, Jong Hyung ; Nam, Hye Young ; Lim, Hyun Ju ; Shin, Jun Seop ; Shin, Jin Young ; Ryu, Ju Hee ; Kim, Kwang Meyung ; Kwon, Ick Chan ; Jin, Sang Man ; Kim, Hang Rae ; Kim, Sang Joon ; Park, Chung Gyu. / In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. In: Journal of Controlled Release. 2012 ; Vol. 162, No. 2. pp. 382-390.
@article{f7cfba0d33394bc9b06bbc5c1bbb200f,
title = "In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation",
abstract = "Maximum engraftment of transplanted islets is essential for the clinical application of a subcutaneous site. Significant barriers to the current approaches are associated with their low effectiveness, complexity and unproven biosafety. Here, we evaluated and optimized a fibrin-islet composite for effective glycemic control in a subcutaneous site whose environment is highly hypoxic due to low vascularization potential. In the setting of xenogeneic porcine islet transplantation into the subcutaneous space of a diabetic mouse, the in vivo islet functions were greatly affected by the concentrations of fibrinogen and thrombin. The optimized hydrogel-type fibrin remarkably reduced the marginal islet mass to approximately one tenth that of islets without fibrin. This marginal islet mass was comparable to that in the setting of the subcapsular space of the kidney, which is a highly vascularized organ. Highly vascularized structures were generated inside and on the outer surface of the grafts. A hydrogel-type fibrin-islet composite established early diabetic control within an average of 3.4 days after the transplantation. In the mechanistic studies, fibrin promoted local angiogenesis, enhanced islet viability and prevented fragmentation of islets into single cells. In conclusion, in situ application of hydrogel-type fibrin-islet composite may be a promising modality in the clinical success of subcutaneous islet transplantation.",
keywords = "Fibrin, Porcine islet, Subcutaneous islet transplantation, Xenotransplantation",
author = "Kim, {Jung Sik} and Lim, {Jong Hyung} and Nam, {Hye Young} and Lim, {Hyun Ju} and Shin, {Jun Seop} and Shin, {Jin Young} and Ryu, {Ju Hee} and Kim, {Kwang Meyung} and Kwon, {Ick Chan} and Jin, {Sang Man} and Kim, {Hang Rae} and Kim, {Sang Joon} and Park, {Chung Gyu}",
year = "2012",
month = "9",
day = "10",
doi = "10.1016/j.jconrel.2012.07.018",
language = "English",
volume = "162",
pages = "382--390",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation

AU - Kim, Jung Sik

AU - Lim, Jong Hyung

AU - Nam, Hye Young

AU - Lim, Hyun Ju

AU - Shin, Jun Seop

AU - Shin, Jin Young

AU - Ryu, Ju Hee

AU - Kim, Kwang Meyung

AU - Kwon, Ick Chan

AU - Jin, Sang Man

AU - Kim, Hang Rae

AU - Kim, Sang Joon

AU - Park, Chung Gyu

PY - 2012/9/10

Y1 - 2012/9/10

N2 - Maximum engraftment of transplanted islets is essential for the clinical application of a subcutaneous site. Significant barriers to the current approaches are associated with their low effectiveness, complexity and unproven biosafety. Here, we evaluated and optimized a fibrin-islet composite for effective glycemic control in a subcutaneous site whose environment is highly hypoxic due to low vascularization potential. In the setting of xenogeneic porcine islet transplantation into the subcutaneous space of a diabetic mouse, the in vivo islet functions were greatly affected by the concentrations of fibrinogen and thrombin. The optimized hydrogel-type fibrin remarkably reduced the marginal islet mass to approximately one tenth that of islets without fibrin. This marginal islet mass was comparable to that in the setting of the subcapsular space of the kidney, which is a highly vascularized organ. Highly vascularized structures were generated inside and on the outer surface of the grafts. A hydrogel-type fibrin-islet composite established early diabetic control within an average of 3.4 days after the transplantation. In the mechanistic studies, fibrin promoted local angiogenesis, enhanced islet viability and prevented fragmentation of islets into single cells. In conclusion, in situ application of hydrogel-type fibrin-islet composite may be a promising modality in the clinical success of subcutaneous islet transplantation.

AB - Maximum engraftment of transplanted islets is essential for the clinical application of a subcutaneous site. Significant barriers to the current approaches are associated with their low effectiveness, complexity and unproven biosafety. Here, we evaluated and optimized a fibrin-islet composite for effective glycemic control in a subcutaneous site whose environment is highly hypoxic due to low vascularization potential. In the setting of xenogeneic porcine islet transplantation into the subcutaneous space of a diabetic mouse, the in vivo islet functions were greatly affected by the concentrations of fibrinogen and thrombin. The optimized hydrogel-type fibrin remarkably reduced the marginal islet mass to approximately one tenth that of islets without fibrin. This marginal islet mass was comparable to that in the setting of the subcapsular space of the kidney, which is a highly vascularized organ. Highly vascularized structures were generated inside and on the outer surface of the grafts. A hydrogel-type fibrin-islet composite established early diabetic control within an average of 3.4 days after the transplantation. In the mechanistic studies, fibrin promoted local angiogenesis, enhanced islet viability and prevented fragmentation of islets into single cells. In conclusion, in situ application of hydrogel-type fibrin-islet composite may be a promising modality in the clinical success of subcutaneous islet transplantation.

KW - Fibrin

KW - Porcine islet

KW - Subcutaneous islet transplantation

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=84865327127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865327127&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2012.07.018

DO - 10.1016/j.jconrel.2012.07.018

M3 - Article

C2 - 22820449

AN - SCOPUS:84865327127

VL - 162

SP - 382

EP - 390

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -